ArticleJournal of oncology2019

Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma.

Andrew D Ludwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.